Covid-19 (SARS-CoV-2), Nucleocapsid, Total Antibody (COVTA)

Covid-19 (SARS-CoV-2), Nucleocapsid, Total Antibody (COVTA)

Welcome to Mayo Clinic's Covid-19 (SARS-CoV-2) Nucleocapsid Total Antibody (COVTA) screening. In the ever-evolving landscape of the Covid-19 pandemic, understanding your immune response is essential. This test is designed to detect antibodies against the virus's nucleocapsid protein, offering insights into your Covid-19 history, immunity status, and vaccination effectiveness.

Click here to view sample COVTA Testing Report:
Covid-19 (SARS-CoV-2), Nucleocapsid, Total Antibody (COVTA)

Uncover Your Covid-19 Immune Status

The First Step Made Easy

Why Choose COVTA Testing?

Decoding COVID-19 Testing: A Detailed Catalog of Diagnostic Methods and Screening Techniques

We're Here To Help!